Home > News > OctoPlus secures Euro 18.25 million in second financing round
January 20th, 2005
OctoPlus secures Euro 18.25 million in second financing round
Abstract:
OctoPlus, a drug delivery and development company announced today that it has raised Euro 18.25 million (US$23.85 million) in a second financing round from an international group of investors. The investment was led by Life Sciences Partners II B.V. and S.R. One, Ltd. Other investors participating in this round of financing are Innoven Partenaires, Fortis Private Equity and SurModics, Inc. Fortis Bank acted as OctoPlus' exclusive financial advisor and placement agent in the financing.
Source:
OctoPlus
Bookmark:
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Announcements
Conference Scheduled June 5-7 on Safe Use of Nanotechnology in Environmental Remediation May 23rd, 2013
Heinrich Rohrer dies at 79; a father of nanotechnology: With IBM colleague Gerd Binnig, Rohrer invented the scanning tunneling microscope, which can show individual atoms on a surface and move them around May 23rd, 2013
Gold nanocrystal vibration captured on billion-frames-per-second film May 23rd, 2013
Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013